Georgiana Florentina Rosulescu

Dr. Georgiana Florentina Rosulescu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Life
Verified
Journal Article
Open access
PDF file
RGRaluca Roxana Grigorescu
Raluca Roxana Grigorescu
IHIoana Alexandra Husar-Sburlan
Ioana Alexandra Husar-Sburlan
GRGeorgiana Florentina Rosulescu
Georgiana Florentina Rosulescu
ABAnca Bobirca
Anca Bobirca
RCRazvan Claudiu Cerban
Razvan Claudiu Cerban
FMFlorescu Madalina
Florescu Madalina
In recent years, we have faced an increasing incidence of inflammatory bowel disease (IBD), especially among young people, affecting them during their reproductive years. The paucity of data and reduced knowledge regarding the evolution of the disease during pregnancy and the adverse effects of the therapy on the mother and infant increase voluntary childlessness in this group of patients. Depending on the type of IBD, severity and surgical or medical management, this can negatively affect the pregnancy. C-sections and the risk of low-birth-weight babies are higher in women with IBD, independent of active/inactive disease, while preterm birth, stillbirth and miscarriage are associated with disease activity. In the last period, medicinal therapy has evolved, and new molecules have been developed for better control of the lesions, but the effect on pregnancy and breastfeeding is still controversial. We conducted this review by studying the literature and recent research in order to have a better image of the practical management of IBD during pregnancy.